Beneo has announced that its whole grain barley flour, Orafti β Fit, has received certification from the American Heart Association (AHA) to carry the organization’s Heart-Check mark.
Beneo (Parsippany, NJ) has announced that its whole grain barley flour, Orafti β Fit, has received certification from the American Heart Association (AHA) to carry the organization’s Heart-Check mark.
“We are extremely proud to have passed the American Heart Association’s strict evaluation criteria and are now able to make use of the well-known and highly valued Heart-Check mark. Products carrying that symbol demonstrate their high nutritional standard, making it easier for consumers to make better food choices,” said Denisse Colindres, manager Nutrition Communication, North America at BENEO, in a press release. “This distinctive mark signifies Orafti β Fit’s compliance with high heart-healthy standards, showing manufacturers at a glance that Orafti β Fit is an ingredient they can trust.”
Beneo cites research from FMCG Gurus stating that two-thirds of North American consumers are interested in heart health products even if they don’t suffer from specific health problems, and a similar number of North Americans agree with the statement, “I find products positioned around improving heart health appealing.” Therefore, there is a strong market potential for new product development with respect to products that have proven health benefits.
Orafti β Fit delivers 20% beta-glucan fibers, which is significantly higher than conventional cereal flours, says Beneo. Research shows that 3 g of barley beta-glucans daily may reduce blood LDL-cholesterol to reduce the risk of coronary heart disease. According to the company, the ingredient can be used in a number of application, from bread to pasta, and provides an opportunity for affordable beta-glucan enrichment.
Reference
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.
Kelker Pharma to launch nutritional support system for GLP-1 medication users that features TriBsyn
December 11th 2024B&D Nutritional Ingredients Inc., an exclusive distribution partner of CarnoSyn Brands and Natural Alternatives International Inc., announced that its customer, Kelker Pharma, will be launching the “first science-backed nutritional support system” for GLP-1 medication users, called Nutrilinq Genesis.